Dynacor Group Announces Public Offering of up to approximately C$20 Million

/NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES/ Dynacor Group Inc. (TSX: DNG) (“Dynacor” or the “Corporation”), is pleased to announce that it entered into an agreement with Canaccord Genuity Corp. (the “Sole Agent”) to offer and sell to the public by way of a prospectus supplement on a […]

Hennessy Capital Investment Corp. VII Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing February 6, 2025

(NasdaqGM:HVII),(NasdaqGM:HVIIR),(NasdaqGM:HVIIU), New York, NY, Jan. 30, 2025 (GLOBE NEWSWIRE) — Hennessy Capital Investment Corp. VII (NASDAQ: HVIIU) (the “Company”) announced that, commencing February 6, 2025, holders of the units sold in the Company's initial public offering may elect to separately trade the Company's Class A ordinary shares and rights included in the units. The Class

Gunderson Dettmer Opens New Office in Atlanta with Addition of Three Corporate Partners

REDWOOD CITY, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) — Gunderson Dettmer, a global leader in the innovation economy, is delighted to announce the addition of three new corporate partners in Atlanta and the official opening of its 12th global office. They will join Jason Cummings, who came to Gunderson Dettmer in 2024 from Arthur Ventures

First Helium Completes Drilling 7-30 Well & Cases for Completion and Testing

(TSX-V:HELI.V),(OTC US:FHELF),(Other OTC:FHELF),(Boerse Frankfurt – Freiverkehr:2MC), CALGARY, Alberta, Jan. 30, 2025 (GLOBE NEWSWIRE) — First Helium Inc. (“First Helium” or the “Company”) (TSXV: HELI) (OTCQB: FHELF) (FRA: 2MC) today announced that it has completed drilling its proven undeveloped (“PUD”) 7-30 oil location at its Worsley Property in Northern Alberta1,2. The 7-30 well has now been

The First of Long Island Corporation Reports Earnings for the Year Ended December 31, 2024

(NASDAQ:FLIC), MELVILLE, N.Y., Jan. 30, 2025 (GLOBE NEWSWIRE) — The First of Long Island Corporation (Nasdaq: FLIC, the “Company” or the “Corporation”), the parent of The First National Bank of Long Island (the “Bank”), reported earnings for the quarter and year ended December 31, 2024. President and Chief Executive Officer Chris Becker commented on the

BioSyent Declares First Quarter 2025 Dividend

(TSX-V:RX), MISSISSAUGA, Ontario, Jan. 30, 2025 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.05 per common share, payable in Canadian Dollars on March 14, 2025, to shareholders of record at the close of business on February

Greenridge Announces Marketing Extension

(CNSX:GXP.CN),(CNSX:GXP),(Frankfurt:HW3),(Pinksheets:GXPLF),(PinkSheets:GXPLF),(OTC US:GXPLF),(Other OTC:GXPLF), VANCOUVER, British Columbia, Jan. 30, 2025 (GLOBE NEWSWIRE) — Greenridge Exploration Inc. (“Greenridge” or the “Company“) (CSE: GXP | FRA: HW3 | OTCQB: GXPLF), is pleased to announce, further to its news release on December 19, 2024, that it has increased the advertising budget under its engagement of marketing services with RMK

Tarsus to Participate in Upcoming Investor Conferences

(NASDAQ:TARS), IRVINE, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management will participate in fireside chats at two upcoming investor conferences: The Guggenheim SMID Cap Biotech Conference on Thursday, February 6th, at 6:00 a.m. PT / 9:00 a.m. ET The Oppenheimer 35th Annual Healthcare Life Sciences Conference on

Koi Computers Integrating Systems Leveraging the Power of Intel Xeon 6 processors for HPC and AI

Koi Computers is now integrating the Intel Xeon 6 processors into a wide range of systems for data centers, AI, Deep Learning, and HPC applications across all industries. As a leading provider of turnkey HPC solutions to the federal government, Koi Computers is positioned to help customers capture the full advantage of the latest generation

Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

(AUST:TLX.AX),(NasdaqGM:TLX), MELBOURNE, Australia and INDIANAPOLIS, Jan. 31, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has completed the acquisition from antibody engineering company ImaginAb, Inc. (ImaginAb). The acquisition includes a pipeline of next-generation therapeutic candidates, a proprietary novel biologics technology platform, and a protein engineering and

Scroll to Top